TCM
IBB icon

Traynor Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.03M Sell
15,875
-5,977
-27% -$763K 0.14% 68
2025
Q1
$2.79M Sell
21,852
-1,107
-5% -$142K 0.24% 61
2024
Q4
$3.04M Sell
22,959
-2,045
-8% -$270K 0.2% 61
2024
Q3
$3.64M Buy
25,004
+2,525
+11% +$368K 0.22% 55
2024
Q2
$3.09M Buy
22,479
+972
+5% +$133K 0.23% 54
2024
Q1
$2.95M Buy
21,507
+2,294
+12% +$315K 0.26% 57
2023
Q4
$2.61M Sell
19,213
-1,009
-5% -$137K 0.27% 53
2023
Q3
$2.47M Buy
20,222
+1,102
+6% +$135K 0.31% 51
2023
Q2
$2.43M Buy
19,120
+492
+3% +$62.5K 0.3% 51
2023
Q1
$2.41M Buy
18,628
+2
+0% +$258 0.35% 47
2022
Q4
$2.45M Buy
18,626
+1,396
+8% +$183K 0.34% 45
2022
Q3
$2.02M Sell
17,230
-1,473
-8% -$172K 0.36% 46
2022
Q2
$2.2M Sell
18,703
-13,361
-42% -$1.57M 0.38% 48
2022
Q1
$4.18M Sell
32,064
-5,534
-15% -$721K 0.54% 41
2021
Q4
$5.74M Sell
37,598
-550
-1% -$83.9K 0.68% 32
2021
Q3
$6.17M Sell
38,148
-287
-0.7% -$46.4K 0.84% 26
2021
Q2
$6.33M Buy
38,435
+2,132
+6% +$351K 0.88% 25
2021
Q1
$5.47M Buy
36,303
+2,443
+7% +$368K 0.9% 26
2020
Q4
$5.13M Sell
33,860
-2,353
-6% -$356K 0.91% 26
2020
Q3
$4.94M Buy
36,213
+1,499
+4% +$205K 1.13% 21
2020
Q2
$4.75M Buy
34,714
+16,438
+90% +$2.25M 1.14% 18
2020
Q1
$1.97M Buy
18,276
+4,939
+37% +$532K 0.7% 34
2019
Q4
$1.61M Sell
13,337
-581
-4% -$70K 0.43% 52
2019
Q3
$1.38M Sell
13,918
-623
-4% -$62K 0.43% 49
2019
Q2
$1.6M Buy
14,541
+29
+0.2% +$3.18K 0.52% 43
2019
Q1
$1.62M Buy
14,512
+544
+4% +$60.8K 0.54% 39
2018
Q4
$1.35M Sell
13,968
-258
-2% -$24.9K 0.56% 35
2018
Q3
$1.73M Buy
14,226
+571
+4% +$69.6K 0.56% 37
2018
Q2
$1.51M Buy
13,655
+1,195
+10% +$132K 0.55% 35
2018
Q1
$1.33M Buy
12,460
+929
+8% +$99.2K 0.54% 36
2017
Q4
$1.23M Buy
11,531
+8,186
+245% +$874K 0.53% 42
2017
Q3
$1.11M Sell
3,345
-363
-10% -$120K 0.53% 43
2017
Q2
$1.18M Buy
3,708
+285
+8% +$91K 0.58% 37
2017
Q1
$1.02M Buy
3,423
+301
+10% +$89.7K 0.57% 35
2016
Q4
$844K Buy
3,122
+214
+7% +$57.9K 0.56% 40
2016
Q3
$777K Buy
2,908
+406
+16% +$108K 0.55% 42
2016
Q2
$650K Sell
2,502
-293
-10% -$76.1K 0.51% 44
2016
Q1
$729K Sell
2,795
-371
-12% -$96.8K 0.58% 40
2015
Q4
$1.07M Buy
3,166
+475
+18% +$161K 0.77% 32
2015
Q3
$816K Buy
2,691
+153
+6% +$46.4K 0.7% 31
2015
Q2
$936K Buy
2,538
+76
+3% +$28K 0.78% 27
2015
Q1
$845K Buy
2,462
+182
+8% +$62.5K 0.81% 24
2014
Q4
$691K Buy
+2,280
New +$691K 0.8% 22